Technical Analysis for AGE - AgeX Therapeutics, Inc.

Grade Last Price % Change Price Change
C 2.01 -4.06% -0.09
AGE closed down 4.06 percent on Friday, February 26, 2021, on approximately normal volume. It was able to find support at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical AGE trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 20 DMA Bearish -4.06%
Stochastic Reached Oversold Weakness -4.06%
Wide Bands Range Expansion -4.06%
Oversold Stochastic Weakness -4.06%
Bullish Engulfing Bullish -10.67%
Crossed Above 20 DMA Bullish -10.67%
Wide Bands Range Expansion -10.67%
Older End-of-Day Signals for AGE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1 ATR 1 day ago
50 DMA Support 1 day ago
3x Volume Pace 1 day ago
2x Volume Pace 1 day ago
1.5x Volume Pace 1 day ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

AgeX Therapeutics, Inc. Description

AgeX is a biotechnology company focused on the development of novel therapeutics for age-related degenerative disease. AgeX’s mission is to apply the proprietary technology platform related to telomerase-mediated cell immortality and regenerative biology to address a broad range of diseases of aging. The current preclinical development efforts include two cell-based therapies derived from telomerase-positive pluripotent stem cells and two product candidates derived from the company’s proprietary induced Tissue Regeneration (iTR™) technology. AGEX-BAT1 and AGEX-VASC1 are cell-based approaches in the preclinical stage of development comprised of young regenerative cells modified using AgeX’s UniverCyte™ technology facilitating immune tolerance, formulated in HyStem® matrix, designed to correct metabolic imbalances in aging and to restore vascular support in ischemic tissues respectively. AGEX-iTR1547 is a drug-based formulation in preclinical development intended to restore regenerative potential in a wide array of aged tissues afflicted with degenerative disease using the company’s proprietary iTR technology. Renelon™ is a first-generation iTR product designed to promote scarless tissue repair which AgeX plans to initially develop as a topically-administered device for commercial development through a 510(k) application. In addition to the product candidates in early development, AgeX, through its LifeMap subsidiary, currently markets genomic interpretation algorithms. AgeX also markets Cytiva® comprised of PSC-derived heart muscle cells used in screening drugs for efficacy and safety.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Diseases Clinical Development Stem Cells Proprietary Technology Cell Biology Product Design Algorithms Degenerative Disease Tissue Engineering Cloning Telomerase Stem Cell

Is AGE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.93
52 Week Low 0.666
Average Volume 329,477
200-Day Moving Average 1.38
50-Day Moving Average 1.92
20-Day Moving Average 2.23
10-Day Moving Average 2.26
Average True Range 0.20
ADX 39.76
+DI 27.15
-DI 24.00
Chandelier Exit (Long, 3 ATRs ) 2.47
Chandelier Exit (Short, 3 ATRs ) 2.30
Upper Bollinger Band 2.76
Lower Bollinger Band 1.70
Percent B (%b) 0.29
BandWidth 47.22
MACD Line 0.07
MACD Signal Line 0.13
MACD Histogram -0.0567
Fundamentals Value
Market Cap 75.75 Million
Num Shares 37.7 Million
EPS -0.32
Price-to-Earnings (P/E) Ratio -6.32
Price-to-Sales 35.85
Price-to-Book 12.96
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.34
Resistance 3 (R3) 2.34 2.22 2.29
Resistance 2 (R2) 2.22 2.14 2.23 2.27
Resistance 1 (R1) 2.12 2.09 2.06 2.12 2.25
Pivot Point 2.00 2.00 1.98 2.01 2.00
Support 1 (S1) 1.90 1.92 1.84 1.90 1.77
Support 2 (S2) 1.78 1.87 1.79 1.75
Support 3 (S3) 1.68 1.78 1.74
Support 4 (S4) 1.68